NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) ROE
- 2026-06-30: ROE 254.73%.
- 2026-03-31: ROE 292.04%.
- 2025-12-31: ROE 354.96%.
- 2025-09-30: ROE 413.70%.
Complete source-backed roe history.
- Available history
- 2024-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|---|
| 2026-06-30 | 254.73% |
| 2026-03-31 | 292.04% |
| 2025-12-31 | 354.96% |
| 2025-09-30 | 413.70% |
| 2025-06-30 | 359.22% |
| 2025-03-31 | 429.00% |
| 2024-12-31 | 216.14% |
Annual ROE
| Date | ROE |
|---|---|
| 2025-12-31 | 354.96% |
| 2024-12-31 | 216.14% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |